Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Lumos Pharma Inc. buy DomRuinart

Lumos Pharma Inc.
Start price
€18.00
11.01.21 / 50%
Target price
€25.00
11.01.22
Performance (%)
-17.22%
End price
€14.90
25.01.21
Summary
This prediction ended on 25.01.21 with a price of €14.90. The prediction for Lumos Pharma Inc. disappointed with a performance of -17.22%. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Lumos Pharma Inc. - - - -
iShares Core DAX® 2,55 % 0,56 % 14,14 % 49,14 %
iShares Nasdaq 100 2,74 % -0,60 % 30,37 % 82,05 %
iShares Nikkei 225® 6,58 % 4,34 % 49,37 % 60,62 %
iShares S&P 500 1,93 % -0,51 % 24,26 % 59,66 %

According to DomRuinart what are the pros and cons of Lumos Pharma Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread NewLink Genetics Corp diskutieren
Prediction Buy
Perf. (%) -17.22%
Target price 25.000
Change
Ends at 11.01.22

Buy mit Kursziel 25,0

DomRuinart 
0
Report Share
11.01.21
In the thread Trading Lumos Pharma Inc.
Prediction Buy
Perf. (%) -17.22%
Target price 25.000
Change
Ends at 11.01.22

Buy beendet

DomRuinart 
0
Report Share
25.01.21